PBMWW — PSYENCE BIOMEDICAL LTD.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1985062 ·
Ontario, Canada
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 0 | — | -1,506,307 | -753,254 | 12,810,145 | 7,149,985 | 943,068 |
| Sep 2024 | 0 | — | -1,157,118 | 141,473 | 2,253,498 | 1,932,519 | 3,508,604 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-58,439,936
Inventory
—
Receivables
$174,187
ST Investments
—
EBIT TTM
$-750,501
Pretax Income TTM
$-753,254
Interest Exp TTM
$2,753
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -5,945,264 | -6,936,421 | 17,567,320 | 623,190 | 16,944,130 | -8,143,007 |
| Mar 2025 | 0 | -3,663,022 | 1,011,790 | 7,316,370 | 594,366 | 6,722,004 | -3,734,238 |
| Mar 2024 | 0 | -43,354,085 | -51,159,048 | 1,132,159 | 12,104,699 | -10,972,540 | -2,945,365 |
| Mar 2023 | 0 | -3,234,869 | -3,206,403 | 1,590,255 | 1,790,700 | -200,445 | -1,592,080 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.06T | $1183.46 | — |
| JNJ | JOHNSON & JOHNSON | $653.61B | $271.22 | — |
| ABBV | AbbVie Inc. | $467.12B | $264.34 | — |
| MRK | Merck & Co., Inc. | $367.07B | $148.78 | — |
| NVS | NOVARTIS AG | $276.48B | $145.46 | — |
News headlines (Yahoo Finance, 1h cache)
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
2026-04-20 11:42 · Yahoo
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
2026-04-17 13:15 · Yahoo
Pacific Bay & Aurwest Sign Weaver Gold Property Definitive Option/JV Agreement
2026-04-14 17:17 · Yahoo
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
2026-04-08 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.